Top posts

On this page, we provide a list of the top 10 posts from the Science of Parkinson’s website (based on the number of views):

The road ahead: Parkinson’s research in 2018 – expectations for 2018 with regards to clinical trials, therapeutics, drugs, treatments

The dilemma of success – a hypothetical problem that we may face in the not so distant future

Non-invasive gene therapy: “You never monkey with the truth” – a novel form of gene therapy for Parkinson’s involving a virus that can be injected in your arm, runs into trouble before reaching the clinic

Food for thought! – a review of research focused on foods that are considered good and bad for Parkinson’s

The Agony and the Ecstasy – the science behind the discovery that an illegal drug could be good for dyskinesias (but only in the short term)

Clinical trials: The Power of One – a discussion about adaptive clinical trials and N-of-1 studies

Making. It. Personal. – the way we test drugs doesn’t make sense. We need to rethink the whole thing

EDITORIAL: That Pfizer news – an opinion piece on Pfizer’s decision to terminate Alzheimer’s and Parkinson’s research

Exenatide: One step closer to joblessness! – an analysis of the results from the Phase II clinical trial of Exenatide in Parkinson’s

Update – Mannitol and Parkinson’s disease – Manna from heaven. An overview of how a website/community called ‘Clinicrowd’ is trying to determine if a sweetener is good for Parkinson’s